Injecto Polymers Limited (BOM:544930)
India · Delayed Price · Currency is INR 97.25
-0.31 (-0.32%)
At close: Oct 1, 2026
Injecto Polymers Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,755 | 2,615 | 1,090 | 962.53 | 876.03 | |
Revenue Growth | 43.62% | 139.78% | 13.29% | 9.87% | 78.54% |
Cost of Revenue | 3,103 | 2,149 | 824.72 | 777.22 | 738.2 |
Gross Profit | 652.63 | 466.2 | 265.76 | 185.31 | 137.83 |
Selling, General & Admin | 48.51 | 29.24 | 16.16 | 10.77 | 76.63 |
Other Operating Expenses | 221.94 | 211.28 | 120.43 | 92.29 | -16.86 |
Operating Expenses | 296.61 | 263.52 | 155.83 | 121.39 | 72.05 |
Operating Income | 356.02 | 202.68 | 109.93 | 63.92 | 65.79 |
Interest Expense | -100.62 | -71.25 | -53.48 | -34.86 | -42.8 |
Interest & Investment Income | 3.89 | 3.12 | 1.1 | 0.37 | 0.14 |
Currency Exchange Gain (Loss) | -2.6 | 0.64 | 0.68 | 0.47 | - |
Other Non Operating Income (Expenses) | -22.21 | -23.23 | -8.83 | -16.63 | -9.39 |
Pretax Income | 234.48 | 111.96 | 49.4 | 13.27 | 13.74 |
Income Tax Expense | 74.35 | 30.87 | 4.97 | -7.39 | 2.08 |
Net Income | 160.13 | 81.09 | 44.44 | 20.66 | 11.66 |
Net Income to Common | 160.13 | 81.09 | 44.44 | 20.66 | 11.66 |
Net Income Growth | 97.46% | 82.49% | 115.08% | 77.22% | -20.50% |
Shares Outstanding (Basic) | 15 | 13 | 13 | 10 | 897 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 12 | 897 |
Shares Change | - | 4.00% | 20.92% | -98.65% | -2.15% |
EPS (Basic) | 10.55 | 6.06 | 3.47 | 2.01 | 0.01 |
EPS (Diluted) | 10.55 | 5.35 | 3.06 | 1.71 | 0.01 |
EPS Growth | 97.10% | 75.14% | 78.72% | 13053.84% | -18.75% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -530.23 | -269.19 | -161.76 | -51.98 | -347.95 |
Free Cash Flow Per Share | -34.94 | -17.74 | -11.08 | -4.31 | -0.39 |
Gross Margin | 17.38% | 17.83% | 24.37% | 19.25% | 15.73% |
Operating Margin | 9.48% | 7.75% | 10.08% | 6.64% | 7.51% |
Profit Margin | 4.26% | 3.10% | 4.08% | 2.15% | 1.33% |
Free Cash Flow Margin | -14.12% | -10.29% | -14.83% | -5.40% | -39.72% |
EBITDA | 382.18 | 225.69 | 129.18 | 82.25 | 78.07 |
EBITDA Margin | 10.18% | 8.63% | 11.85% | 8.54% | 8.91% |
D&A For EBITDA | 26.16 | 23.01 | 19.25 | 18.33 | 12.28 |
EBIT | 356.02 | 202.68 | 109.93 | 63.92 | 65.79 |
EBIT Margin | 9.48% | 7.75% | 10.08% | 6.64% | 7.51% |
Effective Tax Rate | 31.71% | 27.57% | 10.05% | - | 15.14% |
Revenue as Reported | 3,758 | 2,619 | 1,098 | 966.18 | 893.03 |
Advertising Expenses | - | - | - | - | 0.05 |